Global Hemoperfusion Production Market Report (Status, Forecast & Strategic Insights)
Market Overview
Hemoperfusion is an extracorporeal treatment technique in which blood is passed over an adsorbent material (sorbent) to remove toxins. It is widely used in cases of liver failure, intoxications, and certain autoimmune diseases. The industry is technology-intensive, with high barriers to entry due to specialized materials and manufacturing processes.
Global production has shown steady growth, increasing from 936K units in 2011 to 1451K units in 2016, with an average growth rate of 9.17%. The market is expected to continue expanding, driven by rising demand for advanced detoxification therapies and broader clinical applications.
Key Players
- Baxter (Gambro)
- Asahi-Kasei Medical
- Kaneka Corporation
- Toray Medical
- Jafron Biomedical
- Biosun Medical
- Cytosorbents Corporation
- Fresenius Medical Care
- Haemonetics Corporation
- Kawasumi Laboratories
- Terumo Corporation
Segments Analysis
By Product Type
- Charcoal Hemoperfusion
- Resin-based Hemoperfusion
- Hybrid Hemoperfusion Systems (emerging segment)
By Application
- Liver (Hepatic) Failure
- Specific Intoxications (drug overdose, poisoning)
- Autoimmune Diseases (e.g., rheumatoid arthritis, lupus)
- Sepsis and Inflammatory Conditions
- Others (experimental and niche applications)
By End User
- Hospitals
- Specialty Clinics
- Research & Academic Institutes
- Dialysis Centers
Regional Analysis
- North America – Strong adoption due to advanced healthcare infrastructure and presence of leading manufacturers.
- Europe – High-end production and innovation; strong regulatory frameworks supporting adoption.
- Asia-Pacific – Fastest-growing region, led by China and India, with rising healthcare investments and local manufacturers.
- Latin America – Emerging adoption in tertiary care hospitals.
- Middle East & Africa – Niche growth driven by modernization of healthcare systems.
Porter’s Five Forces
- Threat of New Entrants – Low; high technology barriers and regulatory requirements.
- Bargaining Power of Suppliers – Moderate; reliance on specialized sorbent materials.
- Bargaining Power of Buyers – High; hospitals and clinics demand cost-effective solutions.
- Threat of Substitutes – Moderate; dialysis and plasmapheresis compete but lack the same detoxification efficiency.
- Industry Rivalry – High; few global players dominate, but regional firms are emerging.
SWOT Analysis
Strengths
- Effective in removing toxins not easily eliminated by dialysis.
- Expanding clinical applications.
- Strong presence of established global players.
Weaknesses
- High production costs due to specialized materials.
- Limited awareness in developing regions.
Opportunities
- Rising demand in Asia-Pacific and Latin America.
- Innovation in sorbent materials for broader applications.
- Integration with other extracorporeal therapies.
Threats
- Price fluctuations in raw materials (polypropylene, activated carbon).
- Regulatory hurdles and reimbursement challenges.
- Competition from alternative therapies.
Trend Analysis
- Increasing use of resin-based hemoperfusion for targeted toxin removal.
- Expansion into sepsis and inflammatory disease management.
- Development of hybrid systems combining hemoperfusion with dialysis or plasma exchange.
- Rising demand in emerging markets due to healthcare infrastructure improvements.
Drivers & Challenges
Drivers
- Growing prevalence of liver failure and intoxications.
- Rising demand for advanced extracorporeal therapies.
- Technological innovations in sorbent materials.
Challenges
- High production and treatment costs.
- Limited skilled workforce for advanced therapies.
- Reimbursement and regulatory barriers in some regions.
Value Chain Analysis
- Raw Materials – Polypropylene, polycarbonate, membranes, activated carbon, resins.
- Manufacturing – Device assembly, sorbent integration, quality testing.
- Distribution – Direct sales, distributors, hospital procurement channels.
- End Users – Hospitals, clinics, dialysis centers, research institutes.
- Support Services – Training, maintenance, clinical support.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in resin-based and hybrid hemoperfusion systems to expand applications.
- Healthcare Providers: Adopt hemoperfusion for sepsis and autoimmune conditions beyond traditional intoxication cases.
- Investors: Focus on Asia-Pacific firms with cost-effective production capabilities.
- Policy Makers: Support reimbursement frameworks to encourage adoption in developing regions.
- Distributors: Strengthen networks in Latin America and Middle East where demand is rising.
Table of Contents
Global Hemoperfusion production Market Research Report 2026
1 Industry Overview of Hemoperfusion production
1.1 Definition and Specifications of Hemoperfusion production
1.1.1 Definition of Hemoperfusion production
1.1.2 Specifications of Hemoperfusion production
1.2 Classification of Hemoperfusion production
1.2.1 Charcoal Hemoperfusion
1.2.2 Certain Resins Hemoperfusion
1.3 Applications of Hemoperfusion production
1.3.1 Liver (Hepatic) Failure
1.3.2 Specific Intoxications
1.3.3 Certain Autoimmune Diseases
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Hemoperfusion production
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hemoperfusion production
2.3 Manufacturing Process Analysis of Hemoperfusion production
2.4 Industry Chain Structure of Hemoperfusion production
3 Technical Data and Manufacturing Plants Analysis of Hemoperfusion production
3.1 Capacity and Commercial Production Date of Global Hemoperfusion production Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Hemoperfusion production Major Manufacturers
3.3 R&D Status and Technology Source of Global Hemoperfusion production Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Hemoperfusion production Major Manufacturers
4 Global Hemoperfusion production Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Hemoperfusion production Capacity and Growth Rate Analysis
4.2.2 Hemoperfusion production Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Hemoperfusion production Sales and Growth Rate Analysis
4.3.2 Hemoperfusion production Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Hemoperfusion production Sales Price
4.4.2 Hemoperfusion production Sales Price Analysis (Company Segment)
5 Hemoperfusion production Regional Market Analysis
5.1 North America Hemoperfusion production Market Analysis
5.1.1 North America Hemoperfusion production Market Overview
5.1.2 North America E Hemoperfusion production Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Hemoperfusion production Sales Price Analysis
5.1.4 North America Hemoperfusion production Market Share Analysis
5.2 Europe Hemoperfusion production Market Analysis
5.2.1 Europe Hemoperfusion production Market Overview
5.2.2 Europe E Hemoperfusion production Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Hemoperfusion production Sales Price Analysis
5.2.4 Europe Hemoperfusion production Market Share Analysis
5.3 China Hemoperfusion production Market Analysis
5.3.1 China Hemoperfusion production Market Overview
5.3.2 China E Hemoperfusion production Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Hemoperfusion production Sales Price Analysis
5.3.4 China Hemoperfusion production Market Share Analysis
5.4 Japan Hemoperfusion production Market Analysis
5.4.1 Japan Hemoperfusion production Market Overview
5.4.2 Japan E Hemoperfusion production Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Hemoperfusion production Sales Price Analysis
5.4.4 Japan Hemoperfusion production Market Share Analysis
5.5 Southeast Asia Hemoperfusion production Market Analysis
5.5.1 Southeast Asia Hemoperfusion production Market Overview
5.5.2 Southeast Asia E Hemoperfusion production Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Hemoperfusion production Sales Price Analysis
5.5.4 Southeast Asia Hemoperfusion production Market Share Analysis
5.6 India Hemoperfusion production Market Analysis
5.6.1 India Hemoperfusion production Market Overview
5.6.2 India E Hemoperfusion production Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Hemoperfusion production Sales Price Analysis
5.6.4 India Hemoperfusion production Market Share Analysis
6 Global E Hemoperfusion production Segment Market Analysis (by Type)
6.1 Global E Hemoperfusion production Sales by Type
6.2 Different Types of Hemoperfusion production Product Interview Price Analysis
6.3 Different Types of Hemoperfusion production Product Driving Factors Analysis
6.3.1 Charcoal Hemoperfusion Growth Driving Factor Analysis
6.3.2 Certain Resins Hemoperfusion Growth Driving Factor Analysis
7 Global E Hemoperfusion production Segment Market Analysis (by Application)
7.1 Global E Hemoperfusion production Consumption by Application
7.2 Different Application of Hemoperfusion production Product Interview Price Analysis
7.3 Different Application of Hemoperfusion production Product Driving Factors Analysis
7.3.1 Liver (Hepatic) Failure of Hemoperfusion production Growth Driving Factor Analysis
7.3.2 Specific Intoxications of Hemoperfusion production Growth Driving Factor Analysis
7.3.3 Certain Autoimmune Diseases of Hemoperfusion production Growth Driving Factor Analysis
7.3.4 Others of Hemoperfusion production Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Hemoperfusion production
8.1 Baxter (Gambro)
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Baxter (Gambro) Hemoperfusion production Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Baxter (Gambro) Hemoperfusion production Business Region Distribution Analysis
8.2 Asahi-Kasei
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Asahi-Kasei Hemoperfusion production Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Asahi-Kasei Hemoperfusion production Business Region Distribution Analysis
8.3 Kaneka
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Kaneka Hemoperfusion production Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Kaneka Hemoperfusion production Business Region Distribution Analysis
8.4 Toray Medical
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Toray Medical Hemoperfusion production Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Toray Medical Hemoperfusion production Business Region Distribution Analysis
9 Development Trend of Analysis of Hemoperfusion production Market
9.1 Global Hemoperfusion production Market Trend Analysis
9.1.1 Global Hemoperfusion production Market Size (Volume and Value) Forecast
9.1.2 Global Hemoperfusion production Sales Price Forecast
9.2 Hemoperfusion production Regional Market Trend
9.2.1 North America Hemoperfusion production Consumption Forecast
9.2.2 Europe Hemoperfusion production Consumption Forecast
9.2.3 China Hemoperfusion production Consumption Forecast
9.2.4 Japan Hemoperfusion production Consumption Forecast
9.2.5 Southeast Asia Hemoperfusion production Consumption Forecast
9.2.6 India Hemoperfusion production Consumption Forecast
9.3 Hemoperfusion production Market Trend (Product Type)
9.4 Hemoperfusion production Market Trend (Application)
10 Hemoperfusion production Marketing Type Analysis
10.1 Hemoperfusion production Regional Marketing Type Analysis
10.2 Hemoperfusion production International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hemoperfusion production by Region
10.4 Hemoperfusion production Supply Chain Analysis
11 Consumers Analysis of Hemoperfusion production
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Hemoperfusion production Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Hemoperfusion production
Table Product Specifications of Hemoperfusion production
Table Classification of Hemoperfusion production
Figure Global Production Market Share of Hemoperfusion production by Type in
Figure Charcoal Hemoperfusion Picture
Table Major Manufacturers of Charcoal Hemoperfusion
Figure Certain Resins Hemoperfusion Picture
Table Major Manufacturers of Certain Resins Hemoperfusion
Table Applications of Hemoperfusion production
Figure Global Consumption Volume Market Share of Hemoperfusion production by Application in
Figure Liver (Hepatic) Failure Examples
Table Major Consumers in Liver (Hepatic) Failure
Figure Specific Intoxications Examples
Table Major Consumers in Specific Intoxications
Figure Certain Autoimmune Diseases Examples
Table Major Consumers in Certain Autoimmune Diseases
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Hemoperfusion production by Regions
Figure North America Hemoperfusion production Market Size (Million USD) (2013-2025)
Figure Europe Hemoperfusion production Market Size (Million USD) (2013-2025)
Figure China Hemoperfusion production Market Size (Million USD) (2013-2025)
Figure Japan Hemoperfusion production Market Size (Million USD) (2013-2025)
Figure Southeast Asia Hemoperfusion production Market Size (Million USD) (2013-2025)
Figure India Hemoperfusion production Market Size (Million USD) (2013-2025)
Table Hemoperfusion production Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hemoperfusion production in
Figure Manufacturing Process Analysis of Hemoperfusion production
Figure Industry Chain Structure of Hemoperfusion production
Table Capacity and Commercial Production Date of Global Hemoperfusion production Major Manufacturers
Table Manufacturing Plants Distribution of Global Hemoperfusion production Major Manufacturers
Table R&D Status and Technology Source of Global Hemoperfusion production Major Manufacturers
Table Raw Materials Sources Analysis of Global Hemoperfusion production Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Hemoperfusion production E
Figure Global E Hemoperfusion production Market Size (Volume) and Growth Rate
Figure Global E Hemoperfusion production Market Size (Value) and Growth Rate
Table E Global Hemoperfusion production Capacity and Growth Rate
Table Global Hemoperfusion production Capacity (K Units) List (Company Segment)
Table E Global Hemoperfusion production Sales (K Units) and Growth Rate
Table Global Hemoperfusion production Sales (K Units) List (Company Segment)
Table E Global Hemoperfusion production Sales Price (USD/Unit)
Table Global Hemoperfusion production Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Hemoperfusion production E
Figure North America E Hemoperfusion production Sales Price (USD/Unit)
Figure North America Hemoperfusion production Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Hemoperfusion production E
Figure Europe E Hemoperfusion production Sales Price (USD/Unit)
Figure Europe Hemoperfusion production Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Hemoperfusion production E
Figure China E Hemoperfusion production Sales Price (USD/Unit)
Figure China Hemoperfusion production Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Hemoperfusion production E
Figure Japan E Hemoperfusion production Sales Price (USD/Unit)
Figure Japan Hemoperfusion production Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Hemoperfusion production E
Figure Southeast Asia E Hemoperfusion production Sales Price (USD/Unit)
Figure Southeast Asia Hemoperfusion production Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Hemoperfusion production E
Figure India E Hemoperfusion production Sales Price (USD/Unit)
Figure India Hemoperfusion production Sales Market Share
Table Global E Hemoperfusion production Sales (K Units) by Type
Table Different Types Hemoperfusion production Product Interview Price
Table Global E Hemoperfusion production Sales (K Units) by Application
Table Different Application Hemoperfusion production Product Interview Price
Table Baxter (Gambro) Information List
Table Product Overview
Table Baxter (Gambro) Hemoperfusion production Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Baxter (Gambro) Hemoperfusion production Business Region Distribution
Table Asahi-Kasei Information List
Table Product Overview
Table Asahi-Kasei Hemoperfusion production Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Asahi-Kasei Hemoperfusion production Business Region Distribution
Table Kaneka Information List
Table Product Overview
Table Kaneka Hemoperfusion production Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Kaneka Hemoperfusion production Business Region Distribution
Table Toray Medical Information List
Table Product Overview
Table Toray Medical Hemoperfusion production Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure Toray Medical Hemoperfusion production Business Region Distribution
Figure Global Hemoperfusion production Market Size (K Units) and Growth Rate Forecast
Figure Global Hemoperfusion production Market Size (Million USD) and Growth Rate Forecast
Figure Global Hemoperfusion production Sales Price (USD/Unit) Forecast
Figure North America Hemoperfusion production Consumption Volume (K Units) and Growth Rate Forecast
Figure China Hemoperfusion production Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe Hemoperfusion production Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia Hemoperfusion production Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan Hemoperfusion production Consumption Volume (K Units) and Growth Rate Forecast
Figure India Hemoperfusion production Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Hemoperfusion production by Type
Table Global Consumption Volume (K Units) of Hemoperfusion production by Application
Table Traders or Distributors with Contact Information of Hemoperfusion production by Region
Key Players
- Baxter (Gambro)
- Asahi-Kasei Medical
- Kaneka Corporation
- Toray Medical
- Jafron Biomedical
- Biosun Medical
- Cytosorbents Corporation
- Fresenius Medical Care
- Haemonetics Corporation
- Kawasumi Laboratories
- Terumo Corporation
Segments Analysis
By Product Type
- Charcoal Hemoperfusion
- Resin-based Hemoperfusion
- Hybrid Hemoperfusion Systems (emerging segment)
By Application
- Liver (Hepatic) Failure
- Specific Intoxications (drug overdose, poisoning)
- Autoimmune Diseases (e.g., rheumatoid arthritis, lupus)
- Sepsis and Inflammatory Conditions
- Others (experimental and niche applications)
By End User
- Hospitals
- Specialty Clinics
- Research & Academic Institutes
- Dialysis Centers
Regional Analysis
- North America – Strong adoption due to advanced healthcare infrastructure and presence of leading manufacturers.
- Europe – High-end production and innovation; strong regulatory frameworks supporting adoption.
- Asia-Pacific – Fastest-growing region, led by China and India, with rising healthcare investments and local manufacturers.
- Latin America – Emerging adoption in tertiary care hospitals.
- Middle East & Africa – Niche growth driven by modernization of healthcare systems.
